Chandra Bhagat Pharma
BSE 542934
4 stories, newest first.
- Board approves preferential allotment of 66 lakh convertible warrants at Rs. 44/- each
- Certificate says corporate governance provisions do not apply for quarter ended 30 September 2026
- BSE grants in-principle approval for preferential issue of 66,00,000 convertible warrants
- Company Secretary & Compliance Officer Rajni Dawani resigns with effect from 30 September 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.